Merck $6 billion revolving credit facility
We advised the agent, arrangers and lenders on the financing
Davis Polk advised the administrative agent in connection with a $6 billion five-year revolving credit facility for Merck & Co. The facility will be used for general corporate purposes.
Merck is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
The Davis Polk finance team included partner James A. Florack and associates Jaynie Doe and John Foster. The tax team included counsel Christopher A. Baratta and associate Justin Corvino. Counsel Will Schisa and associate Chris Looney provided sanctions advice. Members of the Davis Polk team are based in the New York and Washington DC offices.